Related references
Note: Only part of the references are listed.A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis
Makoto Kawashima et al.
JOURNAL OF DERMATOLOGY (2023)
Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model
Nadja Uhlig et al.
ANTIVIRAL RESEARCH (2021)
A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections
Christian Gege et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and-2
Lauren A. Sadowski et al.
VIRUSES-BASEL (2021)
Alphaherpesvirus Latency and Reactivation with a Focus on Herpes Simplex Virus
Nancy M. Sawtell et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
Charlotte James et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction
Jessica R. Doll et al.
PLoS Pathogens (2020)
Use of the Guinea pig model of genital herpes to evaluate vaccines and antivirals: Review
David Bernstein
ANTIVIRAL RESEARCH (2020)
The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model
David Bernstein et al.
NPJ VACCINES (2020)
Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link
Ruth F. Itzhaki et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Neonatal herpes simplex virus infections
Swetha G. Pinninti et al.
SEMINARS IN PERINATOLOGY (2018)
Herpes Simplex Encephalitis: an Update
John W. Gnann et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Approved Antiviral Drugs over the Past 50 Years
Erik De Clercq et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management
Jocelyne Piret et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2016)
De Novo Herpes Simplex Virus VP16 Expression Gates a Dynamic Programmatic Transition and Sets the Latent/Lytic Balance during Acute Infection in Trigeminal Ganglia
Nancy M. Sawtell et al.
PLOS PATHOGENS (2016)
Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease
Steven A. Harris et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Helicase-Primase Inhibitor Pritelivir for HSV-2 Infection
Anna Wald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial
Andrew Mujugira et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
The herpes simplex virus type 1 latency associated transcript locus is required for the maintenance of reactivation competent latent infections
Richard L. Thompson et al.
JOURNAL OF NEUROVIROLOGY (2011)
Effect of ASP2151, a Herpesvirus Helicase-Primase Inhibitor, in a Guinea Pig Model of Genital Herpes
Kiyomitsu Katsumata et al.
MOLECULES (2011)
De Novo Synthesis of VP16 Coordinates the Exit from HSV Latency In Vivo
Richard L. Thompson et al.
PLOS PATHOGENS (2009)
Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency
NM Sawtell et al.
JOURNAL OF VIROLOGY (2006)
Agents and strategies in development for improved management of herpes simplex virus infection and disease
G Kleymann
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Once-daily valacyclovir to reduce the risk of transmission of genital herpes
L Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation
NM Sawtell
JOURNAL OF VIROLOGY (2003)
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy
TH Bacon et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection
N Bourne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
